Loading chart…
PRE-MARKET
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc.
RPG Life Sciences Limited (RPGLIFE) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The RPGLIFE share price is ₹2,596.00 (+1.66% today), with a market capitalisation of ₹43B and a price-to-earnings (P/E) ratio of 38.7. MarketRipple tracks the RPGLIFE investment thesis, the ripple-chain impact of market events on RPG Life Sciences Limited, and the Healthcare sector outlook.
Open
₹2,581.30
High
₹2,649.30
Low
₹2,573.00
Prev. Close
₹2,553.70
52W High
₹3,127.80
52W Low
₹1,733.00
Day range
₹2,573.00–₹2,649.30
52-week range
₹1,733.00–₹3,127.80
Volume
8K
P/E
38.7
ROE
15.6%
D/E
0.03
Margin
14.3%
RPG Life Sciences Limited (NSE: RPGLIFE) is currently trading at ₹2,596.00 (+1.66%).
RPG Life Sciences Limited's market capitalization is ₹43B.
RPG Life Sciences Limited's price-to-earnings (P/E) ratio is 38.7.
RPG Life Sciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on RPG Life Sciences Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.